Estimation of Plasma Triglyceride Level among Patients with Diabetes Mellitus, Wad Medani, Gezira State, Sudan, in 2022
DOI:
https://doi.org/10.37375/sjms.v3i1.2883Keywords:
Triglyceride, Glycosylated Hemoglobin, Diabetes mellitus, Sudan.Abstract
Background: In Sudan and around the world, Diabetes Mellitus is a growing health concern. It is a serious, ongoing condition. The Middle East and North Africa area (MENA) area, which includes Sudan, has the world's highest prevalence of diabetes. It was predicted to be about 25%. More concerning is the prediction that by 2030.
Patients and Methods: This is a case control study conducted in Aldaraga Health Center for Diabetes Care and Wad Medani Pediatric Teaching Hospital, Wad Medani, Gezira State, Sudan to estimate the plasma triglyceride level among diabetic patients. A total of 160 participants were included in the study, ninety patients were case group (Diabetic patients), their mean age was (40.90±24.00) years and seventy were control group (Healthy individuals) their mean age was (45.78±22.38) years. Among case, 37 (41%) were males while 53 (59%) were females. Data were collected by using questionnaire and analyzed by computer program SPSS (Version 20). After fasting (8-12) hours, 2 ml of heparinized plasma and 1.5 ml EDTA whole blood was collected for estimation of triglyceride and HbA1c respectively and then plasma was stored at -200C till assay was done by Cobas C 311.
Results: It revealed high rate of poor glycemic control in Sudanese diabetic patients (81%). There were significance differences in plasma triglyceride between diabetic patients and control group (P value =0.002), age groups (P value =0.000), and gender (P value =0.019). However, there were no statistically significant differences when compared plasma triglyceride levels with glycosylated hemoglobin and duration of the disease (P values = 0.514 and 0.096 respectively).
Conclusion: Diabetes, age, and gender, but not glycosylated hemoglobin or disease duration, were found to have an impact on triglyceride levels in this study.
References
Almakey EA, Makeen AM, Saeed OK, Mohamedahmed KA. Association between Adiponectin and Insulin Resistance among Sudanese Males with Type 2 Diabetes Mellitus. 2021.
Mohamedahmed K, Mohammed RM, Talha AA. Prevalence of Anemia among Patients with Type II Diabetes Mellitus, Alkhair Medical Center, Wad Medani, Gezira State, Sudan (2020). Alkhair Medical Center, Wad Medani, Gezira State, Sudan. 2020.
Almobarak AO, Noor SK, Elmadhoun WM, Bushara SO, Salim RS, Forawi SA, et al. Metabolic control targets in Sudanese adults with type 1 diabetes: A population-based study. Journal of Family Medicine and Primary Care. 2017;6(2):374.
Fiagbe J, Bosoka S, Opong J, Takramah W, Axame W, Owusu R, et al. Prevalence of controlled and uncontrolled diabetes mellitus and associated factors of controlled diabetes among diabetic adults in the hohoe municipality of Ghana. Diabetes Management. 2017;7(5):343-54.
Omar SM, Musa IR, Osman OE, Adam I. Assessment of glycemic control in type 2 diabetes in the Eastern Sudan. BMC research notes. 2018;11(1):1-5.
Ismail KH. Lipid profile of controlled and uncontrolled diabetics in Erbil, Iraq. Iraqi J Comm Med. 2014;1:10-3.
Abdelazeem H, Mergani A, Mohammed Y, Nour BYM. Association of Hyperhomocysteinaemia with Hyperglycaemia, Dyslipidaemia, Hypertension and Obesity. International Journal of Clinical Medicine. 2022;13(8):405-14.
Dixit AK, Dey R, Suresh A, Chaudhuri S, Panda AK, Mitra A, et al. The prevalence of dyslipidemia in patients with diabetes mellitus of ayurveda Hospital. Journal of Diabetes & Metabolic Disorders. 2014;13(1):1-6.
Davidson M, Hu T, Sain G, Hoar B, Stevenson C, Hoogwerf B. The relationship of glycaemic control and triglycerides in patients with diabetes mellitus: a PreCIS Database Study. Diabetes, Obesity and Metabolism. 2009;11(2):118-22.
Jialal I, Amess W, Kaur M. Management of hypertriglyceridemia in the diabetic patient. Current diabetes reports. 2010;10(4):316-20.
Noor SK, Elmadhoun WM, Bushara SO, Almobarak AO, Salim RS, Forawi SA, et al. Glycaemic control in Sudanese individuals with type 2 diabetes: Population based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2017;11:S147-S51.
Mohamed RAA, Noor BYM, Ahmed SM, Dafalla AM, abdelhameed Mohammed Y, Modawe GO. Assessment of Lipid Profile among Sudanese patients with Type 2 Diabetes Mellitus. Al-Kindy College Medical Journal. 2022;18(1):30-5.
Azad AH, Khan HR, Nasir GM, Afzal M. Lipid Profile Abnormalities in Controlled and Uncontrolled Diabetic Patients: A Comparative Study. Annals of PIMS ISSN. 2017;1815:2287.
Mullugeta Y, Chawla R, Kebede T, Worku Y. Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation. Indian Journal of Clinical Biochemistry. 2012;27(4):363-9.
VinodMahato R, Gyawali P, Raut PP, Regmi P, Singh KP, Pandeya DR, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: Glycated haemoglobin as a dual biomarker. Biomedical Research (0970-938X). 2011;22(3).
